Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
Phenol, paraalkylation products with C12-rich branched olefins derived from propene oligomerisation, reaction products with sulphur monochloride and decene, reaction products with Benzoic acid, 2-hydroxy-,C14-18 alkyl dervis., polybutenyl benzenesulphonic acid, carbon dioxide and calcium hydroxide
EC number: 903-162-9 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
EC 903-162-9 was found to be non irritating in an in vitro skin study conducted to GLP standards and in accordance with OECD guidelines.
EC 903-162-9 was found to be non irritating in both an in vitro eye irritation study conducted to GLP standards and subsequently an in vivo study conducted in accordance with OECD guidelines and to GLP standards.
Key value for chemical safety assessment
Skin irritation / corrosion
Link to relevant study records
- Endpoint:
- skin irritation / corrosion
- Remarks:
- other: In Vitro study conducted in accordance with OECD 439 guidance
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 18 January 2012 to 01 June 2012
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Study conducted in accordance with current guidelines and GLP compliant.
- Qualifier:
- according to guideline
- Guideline:
- other: OECD (2010), In Vitro Skin Irritation: Reconstructed Human Epidermis Test Method, OECD Guidelines for the Testing of Chemicals No. 439, OECD, Paris.
- GLP compliance:
- yes
- Remarks on result:
- other: EpiSkin viability of 103.09% ±13.43% (mean of triplicate values). EC 903-162-9 was demonstrated to be non-irritant when tested in the EpiSkin in vitro irritation assay.
- Irritant / corrosive response data:
- EpiSkin viability of 103.09% ±13.43% (mean of triplicate values)
- Interpretation of results:
- not irritating
- Remarks:
- Migrated information Criteria used for interpretation of results: OECD GHS
- Conclusions:
- In conclusion, EC 903-162-9 was demonstrated to be non-irritant when tested in the EpiSkin in vitro irritation assay.
- Executive summary:
Evaluation of skin irritation is part of the Human Health Hazard Assessment required for registration of a chemical. In this study, the irritation potential of EC 903-162-9 was evaluated using the SkinEthic EpiSkin in vitro irritation assay. Prior to the conduct of the irritation assay, a preliminary test was conducted to assess the intrinsic ability of the test item to reduce methylthiazoldiphenyl-tetrazolium bromide (MTT) to formazan. The test item was capable of MTT reduction. Therefore, non-viable control tissues were dosed in parallel with the irritation assay to quantify this effect and the results were corrected accordingly. The dermal irritation potential was assessed by applying an aliquot ca 10 µL of EC 903-162-9 to the exposed surface of three EpiSkin reconstructed human epidermis (RhE) units for 15 min. The surface area of the EpiSkin was 0.38 cm2, therefore the application rate was 26.3 µL/cm2. After the 15 min exposure period, the test item was washed from the surface of the EpiSkin using Dulbecco’s phosphate-buffered saline (PBS) and tissue swabs. The EpiSkin was then incubated for a recovery period of ca 41 h in a humidified incubator set to maintain temperature and CO2 levels of 37°C and 5%, respectively. Following incubation, the EpiSkin units were transferred to assay medium containing MTT (0.3 mg/mL) and returned to the incubator for 3 h. Biopsies of the EpiSkin membranes were then removed, added to acidified isopropanol, and refrigerated for ca 69 h in order to extract the formazan. The formazan production (cell viability) was assessed by measuring the optical density of the extracts at a wavelength of 550 nm. Three replicates of the positive control, aqueous sodium dodecyl sulphate (SDS) solution (5%, w/v) (10 µL), and the negative control, PBS (10 µL) were tested in parallel to demonstrate the efficacy of the assay. The viability of each individual EpiSkin tissue was calculated as a percentage of the mean negative control viability (defined as 100%). Exposure to EC-903-162-9 resulted in a mean EpiSkin viability of 103.09% ± 13.43% of the negative control value. Exposure to the positive control, aqueous SDS solution (5%, w/v), resulted in a mean EpiSkin viability of 13.22% ± 0.35% of the negative control value. In conclusion, EC 903-162-9 was demonstrated to be non-irritant when tested in the EpiSkin in vitro irritation assay.
Reference
MTT Direct Reduction Test (Preliminary Assay)
The test was scored by visual assessment of the formation of purple-coloured formazan. The negative control (PBS) did not reduce MTT to formazan. The positive control (eugenol) and EC 903-162-9 were reduced MTT to formazan.
EpiSkin®Irritation Test
Percentage Viability of EpiSkin® Tissues After ca 41h Recovery Time.
Treatment |
Mean viability per tissue (%) |
Mean viability per test item (%) |
SD (%) |
EC 903-162-9 (corrected) |
91.31 |
103.09 |
13.43 |
100.26 |
|||
117.71 |
|||
Aqueous SDS Solution (5%, w/v) (Positive Control) |
12.82 |
13.22 |
0.35 |
13.39 |
|||
13.44 |
|||
PBS Solution (Negative Control) |
105.31 |
100.00 |
7.75 |
91.10 |
|||
103.59 |
Negative Controls
The negative control results were similar for the three viable EpiSkin®units dosed with
Dulbecco’s PBS. Exposure to Dulbecco’s PBS resulted in a mean EpiSkin®viability of
100.00% ±7.75%.
Positive Controls
The positive control results were similar for the three viable EpiSkin® units dosed with
aqueous SDS solution (5%, w/v). Exposure to aqueous SDS solution (5%, w/v) resulted in amean EpiSkin® viability of 13.22% ±0.35%.
EC 903-162-9
Non-Viable Controls
The mean absorbance value of the three replicate non-viable tissues dosed with EC 903-162-9 was 0.148 ± 0.034. The mean absorbance value of the three replicate un-dosed non-viable tissues was 0.098±0.016. Therefore, the absorbance value for the effect of the un-removed test item was 0.050. This value was subtracted from the absorbance value of the viable tissues dosed with EC-903-162-9.
Viable Tissues
The results were similar for the three viable EpiSkin®units dosed with EC 903-162-9.
Exposure to EC 903-162-9 resulted in a mean EpiSkin®viability (corrected for effect of un-removed test item) of 103.09% ± 13.43% of the negative control value.
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Link to relevant study records
- Endpoint:
- eye irritation: in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 29 January to 08 February 2013
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Compliant with current guidelines and GLP compliant
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 405 (Acute Eye Irritation / Corrosion)
- Deviations:
- no
- GLP compliance:
- yes
- Species:
- rabbit
- Strain:
- New Zealand White
- Details on test animals or tissues and environmental conditions:
- TEST ANIMALS
- Source: Born at Charles River, Edinburgh
- Age at study initiation: Approximately 9 months old
- Weight at study initiation: 4.525 kg and 4.127 kg
- Housing: Singly housed
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: At least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 18°C on each day
- Humidity (%): 42% to 58%
- Air changes (per hr): 10
- Photoperiod (hrs dark / hrs light): 12 hrs light / 12 hrs dark
IN-LIFE DATES: From: To: 29 January to 08 February 2013 - Vehicle:
- unchanged (no vehicle)
- Controls:
- not required
- Amount / concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 0.1 mL
- Concentration (if solution): Not applicable - Duration of treatment / exposure:
- Single dose
- Observation period (in vivo):
- 72 h
- Number of animals or in vitro replicates:
- Two
- Details on study design:
- REMOVAL OF TEST MATERIAL
- Washing (if done): None
SCORING SYSTEM:
OECD Test Guideline scoring system
TOOL USED TO ASSESS SCORE: Hand held magnifier and pen torch (when necessary). When required only, fluorescein and ultraviolet illumination - Irritation parameter:
- overall irritation score
- Basis:
- mean
- Time point:
- other: 24, 48 and 72 h
- Score:
- 0
- Max. score:
- 0
- Reversibility:
- other: Not applicable
- Other effects:
- Slight ocular discharge at 1 h and 4 h post instillation
- Interpretation of results:
- not irritating
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Using the criteria described in regulation (EC) 1272/2008, under the conditions of the study, EC 903-162-9 would be considered to be non-irritating to the rabbit eye.
This study is considered to be relevant, reliable and adequate for risk assessment and for classification purposes. - Executive summary:
- This study investigated the eye
irritation potential of EC-903-162-9 after a single instillation to the
rabbit eye.
Two female rabbits received 0.1 mL of EC-903-162-9, instilled, as supplied, into the conjunctival sac of the right eye. The left eye remained untreated and hence it acted as a control. Both eyes were examined for evidence of irritation approximately 1, 4, 24, 48 and 72 h after instillation.
No irritation was noted in the control eyes of either rabbit at any observation timepoint.
There were no reactions in the iris of either animal. Corneal opacity, slight conjunctival redness and a slight discharge were noted 1 h after test item instillation in one animal. However, after the eye was stained with Fluorescein and the eye examined under ultraviolet illumination, no area of opacity was found. Slight discharge was noted 4 h after test item instillation in both animals.
Using the criteria described in the European Union Council Directive 67/548/EEC and Regulation (EC) No 1272/2008 (CLP) under the conditions of the study, EC-903-162-9 would be considered to be non-irritating to the rabbit eye.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Respiratory irritation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Additional information
Dermal Irritation
The in vitro skin irritation study conducted in accordance with OECD guideline 439, using the EpiSkin test system showed the registration substance to be non irritating, this data combined with lack of irritation seen during an acute dermal study on a structurally similar material (EC 903-161-3) up to the limit dose tested is sufficient to conclude that the material is not a dermal irritant. This testing strategy complies with that set out in REACH Annex VII and VIII.
Eye Irritation
The in vitro eye irritation study showed the registration substance to be non irritating within this test system. From this data it was considered that progression to in vivo eye irritation study was appropriate as there was no indication that the registration material was either corrosive or irritating to the eyes. No eye irritation was seen in the in vivo eye irritation study which was conducted in accordance with OECD 405 guidelines and to GLP standards. It was therefore concluded that the registration substance is not irritating to the eyes. This testing strategy complies with that set out in REACH Annex VII and VIII.
Justification for selection of skin irritation / corrosion endpoint:
Key study conducted in accordance with OECD guideline 439 and GLP.
Justification for selection of eye irritation endpoint:
Key study conducted in accordance with OECD guideline 405 and GLP.
Justification for classification or non-classification
Neither the in vitro Episkin test system that tested EC 903-162-9 or the acute dermal toxicity study on the read-across analogue substance produced any signs of dermal irritation that would warrant classification under Regulation (EC) No 1272/2008 (CLP).
Neither the in vitro eye irritation study nor the in vivo eye irritation study of EC 903-162-9 produced any signs of eye irritation that would warrant classification under Regulation (EC) No 1272/2008 (CLP).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.